Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 8 (3), 173-86

CB Receptor Ligands From Plants


CB Receptor Ligands From Plants

Karin Woelkart et al. Curr Top Med Chem.


Advances in understanding the physiology and pharmacology of the endogenous cannabinoid system have potentiated the interest of cannabinoid receptors as potential therapeutic targets. Cannabinoids have been shown to modulate a variety of immune cell functions and have therapeutic implications on central nervous system (CNS) inflammation, chronic inflammatory conditions such as arthritis, and may be therapeutically useful in treating autoimmune conditions such as multiple sclerosis. Many of these drug effects occur through cannabinoid receptor signalling mechanisms and the modulation of cytokines and other gene products. Further, endocannabinoids have been found to have many physiological and patho-physiological functions, including mood alteration and analgesia, control of energy balance, gut motility, motor and co-ordination activities, as well as alleviation of neurological, psychiatric and eating disorders. Plants offer a wide range of chemical diversity and have been a growing domain in the search for effective cannabinoid ligands. Cannabis sativa L. with the known plant cannabinoid, Delta(9-)tetrahydrocannabinol (THC) and Echinacea species with the cannabinoid (CB) receptor-binding lipophilic alkamides are the best known herbal cannabimimetics. This review focuses on the state of the art in CB ligands from plants, as well their possible therapeutic and immunomodulatory effects.

Similar articles

  • Cannabinoids
    F Grotenhermen. Curr Drug Targets CNS Neurol Disord 4 (5), 507-30. PMID 16266285. - Review
    Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of …
  • Cannabimimetic Plants: Are They New Cannabinoidergic Modulators?
    A Kumar et al. Planta 249 (6), 1681-1694. PMID 30877436. - Review
    Phytochemicals and secondary metabolites able to interact with the endocannabinoid system (Cannabimimetics) have been recently described in a broad range of plants and fr …
  • New Natural Noncannabinoid Ligands for Cannabinoid type-2 (CB2) Receptors
    J Gertsch et al. J Recept Signal Transduct Res 26 (5-6), 709-30. PMID 17118807. - Review
    Since the discovery that Delta 9-tetrahydrocannabinol and related cannabinoids from Cannabis sativa L. act on specific physiological receptors in the human body and the s …
  • Therapeutic Potential of Cannabinoids in CNS Disease
    JL Croxford. CNS Drugs 17 (3), 179-202. PMID 12617697. - Review
    The major psychoactive constituent of Cannabis sativa, delta(9)-tetrahydrocannabinol (delta(9)-THC), and endogenous cannabinoid ligands, such as anandamide, signal throug …
  • Endocannabinoid System: A Multi-Facet Therapeutic Target
    R Kaur et al. Curr Clin Pharmacol 11 (2), 110-7. PMID 27086601. - Review
    Cannabis sativa is also popularly known as marijuana. It has been cultivated and used by man for recreational and medicinal purposes since many centuries. Study of cannab …
See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources